Oblique Therapeutics AB (publ.) will be at the 3rd RAS/MAPK Pathway Targeted Drug Discovery Summit
Our Chief Development Officer: SREESHA P SRINIVASA, PH.D. will take part as speaker at the 3rd RAS/MAPK Pathway Targeted Drug Discovery Summit, February 22-24, 2022. Boston MA